EPO Patents = 4

Forward Citations = 23

Loading Chart...

7 inventors (with patents filed for the assignee):

Yves Claude Nicolau (6 out of 13 patents)

Ruth Greferath (6 out of 12 patents)

Jean-Marie Lehn (6 out of 29 patents)

4. Konstantina C Fylaktakidou (6 out of 7 patents)

5. Claudine Kieda (5 patents)

6. Claude Nicolau (5 patents)

7. Jean Marie Lehn (0 patent)

6 patents: Sort by Forward Citations

1. 9078908 - Inositol pyrophosphates, and methods of use thereof (2015-07-14),

2. 8178514 - Inositol pyrophosphates, and methods of use thereof (2012-05-15),

3. 7919481 - Inositol pyrophosphates, and methods of use thereof (2011-04-05),

4. 7745423 - Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin (2010-06-29),

5. 7648970 - Inositol pyrophosphates, and methods of use thereof (2010-01-19),

6. 7618954 - Inositol pyrophosphates, and methods of use thereof (2009-11-17),

Normoxys, Inc. is a biotechnology company focused on developing innovative solutions for oxygen therapy. Our mission is to improve the lives of patients by providing cutting-edge technologies to ensure proper oxygenation. With a team of experienced scientists and engineers, we are dedicated to creating advanced products that address the challenges of oxygen therapy in various clinical settings. Our ultimate goal is to revolutionize the way oxygen is delivered and administered, leading to better patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

6 Patents

#269 in Boston, MA

#2,472 in Massachusetts

#43,751 in US

Boston, MA, United States of America

Normoxys, Inc.